Package 0615-8220-39

Brand: oxybutynin

Generic: oxybutynin
NDC Package

Package Facts

Identity

Package NDC 0615-8220-39
Digits Only 0615822039
Product NDC 0615-8220
Product ID 0615-8220_0119c939-6479-4c0e-894e-aa7de0572b81
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8220-39)

Marketing

Marketing Status
Marketed Since 2018-06-28
Brand oxybutynin
Generic oxybutynin
Sample Package No

Linked Drug Pages (1)

oxybutynin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0119c939-6479-4c0e-894e-aa7de0572b81", "openfda": {"unii": ["L9F3D9RENQ"], "rxcui": ["863619"], "spl_set_id": ["ec4fd95f-16dc-4acf-b560-b67b7aaef08b"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8220-39)", "package_ndc": "0615-8220-39", "marketing_start_date": "20180628"}], "brand_name": "oxybutynin", "product_id": "0615-8220_0119c939-6479-4c0e-894e-aa7de0572b81", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "0615-8220", "generic_name": "oxybutynin", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "oxybutynin", "active_ingredients": [{"name": "OXYBUTYNIN CHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA202332", "marketing_category": "ANDA", "marketing_start_date": "20170810", "listing_expiration_date": "20261231"}